Watch the video
In this CSA webinar, Executive Director Brenda Delodder and rheumatologist Dr. Sherry Rohekar explore the urgent need for better coordinated care for enteropathic arthritis (EnA)—a condition that links inflammation in the gut and joints and is often overlooked in patients with Crohn’s disease or ulcerative colitis. They discuss how delayed diagnosis, limited awareness of joint symptoms within IBD care, and gaps between gastroenterology and rheumatology contribute to poor patient outcomes across Canada. Dr. Rohekar emphasizes the importance of collaboration between specialists, noting that some treatments can address both gut and joint inflammation while others cannot, making communication essential for effective disease management.
The conversation also highlights key strategies for improving patient empowerment and quality of life. Dr. Rohekar encourages individuals to track symptoms, advocate for referrals, and stay informed about their condition. She outlines the role of lifestyle choices—including stress management, pacing, physical activity, and a balanced diet—in reducing inflammation and flare severity. The session concludes with a look at emerging research on the gut microbiome and personalized medicine, offering hope for more targeted treatments in the future. Together, the discussion underscores how coordinated, patient-centered care can help Canadians live well with enteropathic arthritis.
